Fas labeling status does not correlate with apoptosis of renal cell carcinoma in vivo

Anticancer Research

Volumn 21, Issue 5, 2001, Pages 3193-3197

  Koga, Fumitaka ^a   Arai, Kyoko ^a   Kamai, Takao ^a   Abe, Hideyuki ^a   Yoshida, Ken Ichiro ^a  

^a TOKYO ROSAI HOSPITAL   (Japan)

Author keywords

Apoptosis; Fas; Renal cell carcinoma

Indexed keywords

FAS ANTIGEN; FAS LIGAND;

APOPTOSIS; ARTICLE; CELL DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD95; APOPTOSIS; CARCINOMA, RENAL CELL; FAS LIGAND PROTEIN; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NEOPLASM STAGING;

EID: 0035572823     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Cellular therapy: Scientific rationale and clinical results in the treatment of metastatic renal-cell carcinoma
2. Molecular cloning and expression of the Fas ligand: A novel member of the tumor necrosis factor family
3. The Fas death factor
4. Involvement of the CD95 (APO-I/Fas) receptor/ligand system in drug-induced apoptosis in leukemia cells
5. Lymphocyte apoptosis induced by CD95 (APO-I/Fas) ligand-expressing tumor cells-a mechanism of immune evasion?
6. The Fas counterattack: Cancer as a site of immune privilege
7. Fas and Fas ligand expression in tumor cells and in vascular smooth-muscle cells of colonic and renal carcinomas
8. Resistance to CD95 (APO-1/Fas)-mediated apoptosis in human renal cell carcinomas: An important factor for evasion from negative growth control
9. Fas (APO-I/CD95) ligand and Fas expression in renal cell carcinomas: Correlation with the prognostic factors
10. Mechanisms of apoptosis in T cells from patients with renal cell carcinoma
11. Killing of Fas ligand-resistant renal carcinoma cells by interleukin-2- and BCG-activated effector cells
12. Fas ligand expression in primary colon adenocarcinomas: Evidence that the Fas counterattack is a prevalent mechanism of immune evasion in human colon cancer
13. Alteration of Fas (Apo-1/CD95) gene in cutaneous malignant melanoma
14. Activation-induced aggregation and processing of human Fas antigen. Detection with cytoplasmic domain-specific antibodies
15. Fas ligand is present in tumors of the Ewing's sarcoma family and is cleaved into a soluble form by a metalloproteinase
16. Apoptosis in renal cell carcinoma: Detection by in situ end-labeling of fragmented DNA and correlation with other prognostic factors
17. Transitional cell carcinoma expresses high levels of Fas ligand in vivo
18. Immunogold silver staining for light microscopy
19. Expression and function of Fas (CD95) on human renal tubular epithelial cells
20. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways
21. Defective granzyme B gene expression and lytic response in T lymphocytes infiltrating human renal cell carcinoma
22. Clinical significance of angiogenesis, proliferation and apoptosis in renal cell carcinoma